1. Neurologic manifestations of Long COVID in Colombia: a comparative analysis of post-hospitalization vs. non-hospitalized patients.
- Author
-
Hurtado C, Rojas-Gualdrón DF, Pérez Giraldo GS, Villegas Arbelaez E, Mantilla SEM, Campuzano-Sierra M, Ospina-Patino S, Arroyave-Bustamante M, Uribe-Vizcarra V, Restrepo-Arbelaez D, Cardona P, Llano-Piedrahita J, Vásquez-Builes S, Agudelo-Quintero E, Vélez-Arroyave J, Menges S, Jimenez M, Miller J, Quique YM, and Koralnik IJ
- Abstract
Objective: To analyze patient-reported outcomes, cognitive function, and persistent symptoms in patients with neurologic post-acute sequelae of SARS-CoV-2 infection (Neuro-PASC) in Colombia., Methods: We recruited patients with laboratory-confirmed COVID-19 and PASC symptoms lasting more than 6 weeks at the CES University and CES Clinic (Medellín, Colombia). We included 50 post-hospitalization Neuro-PASC (PNP) and 50 non-hospitalized Neuro-PASC (NNP) patients. Long-COVID symptoms, cognitive (NIH Toolbox v2.1-Spanish for 18+), patient-reported (PROMIS) outcomes, and relevant medical history were evaluated. Statistical analyses were performed via generalized linear models., Results: Overall, brain fog (60%), myalgia (42%), and numbness or tingling (41%) were the most common neurological symptoms, while fatigue (74%), sleep problems (46%), and anxiety (44%) were the most common non-neurological symptoms. Compared to NNP, PNP patients showed a higher frequency of abnormal neurological exam findings (64% vs. 42%, p = 0.028). Both groups had impaired quality of life (QoL) in domains of cognition, fatigue, anxiety depression and sleep disturbance, and performed worse on processing speed and attention than a normative population. In addition, NNP patients performed worse on executive function than PNP patients (T-score 42.6 vs. 48.5, p = 0.012). PASC symptoms of anxiety and depression were associated with worse QoL and cognitive outcomes. Brain fog and fatigue remained persistent symptoms across all durations of Long COVID., Conclusion: Our findings highlight the high incidence and heterogeneity of the neurologic symptoms and impacts of Long COVID even more than 2 years from disease onset. Early detection, emotional support and targeted management of Neuro-PASC patients are warranted., Competing Interests: IK receives royalties from UpToDate for a chapter on neurologic manifestations of COVID-19. YQ was employed by Shirley Ryan AbilityLab. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Hurtado, Rojas-Gualdrón, Pérez Giraldo, Villegas Arbelaez, Medina Mantilla, Campuzano-Sierra, Ospina-Patino, Arroyave-Bustamante, Uribe-Vizcarra, Restrepo-Arbelaez, Cardona, Llano-Piedrahita, Vásquez-Builes, Agudelo-Quintero, Vélez-Arroyave, Menges, Jimenez, Miller, Quique and Koralnik.)
- Published
- 2024
- Full Text
- View/download PDF